Trends in long-term opioid therapy for chronic non-cancer pain

Pharmacoepidemiology and Drug Safety

Volumn 18, Issue 12, 2009, Pages 1166-1175

  Boudreau, Denise ^a   Von Korff, Michael ^a   Rutter, Carolyn M ^a   Saunders, Kathleen ^a   Ray, G Thomas ^b   Sullivan, Mark D ^c   Campbell, Cynthia I ^b   Merrill, Joseph O ^c   Silverberg, Michael J ^b   Banta Green, Caleb ^d   Weisner, Constance ^b,e  

^a CENTER FOR HEALTH STUDIES   (United States)

^b DIVISION OF RESEARCH   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Analgesic; Hydrocodone; Morphine; Opioids; Oxycodone; Pain; Prevalence; Trends

Indexed keywords

ACETYLSALICYLIC ACID; BUTALBITAL; COCODAMOL; CODEINE SULFATE; DEXTROPROPOXYPHENE; DIHYDROCODEINE; FENTANYL; HYDROCODONE; HYDROMORPHONE; HYPNOTIC SEDATIVE AGENT; LEVORPHANOL; METHADONE; MORPHINE SULFATE; NARCOTIC ANALGESIC AGENT; OXYCODONE; OXYMORPHONE; PENTAZOCINE; PETHIDINE; TRAMADOL;

ADULT; ARTICLE; CHRONIC PAIN; CONTROLLED STUDY; DRUG USE; FEMALE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PHARMACEUTICAL CARE; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; TREND STUDY; UNITED STATES;

ADULT; AGED; ANALGESICS, OPIOID; DRUG ADMINISTRATION SCHEDULE; DRUG PRESCRIPTIONS; DRUG UTILIZATION; FEMALE; HUMANS; LONG-TERM CARE; MALE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; TIME FACTORS;

EID: 67651094525     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1833     Document Type: Article

References (54)

1. Zerzan JT, Morden NE, Soumerai S, et al. Trends and geographic variation of opiate medication use in state Medicaid fee-for-service programs, 1996 to 2002. Med Care 2006; 44(11): 1005-1010.
2. Joranson DE, Ryan KM, Gilson AM, Dahl JL. Trends in medical use and abuse of opioid analgesics. JAMA 2000; 283(13): 1710-1714.
3. Williams RE, Sampson TJ, Kalilani L, Wurzelmann JI, Janning SW. Epidemiology of opioid pharmacy claims in the United States. J Opioid Manag 2008; 4(3): 145-152.
4. Brixner DI, Oderda GM, Roland CL, Rublee DA. Opioid expenditures and utilization in the Medicaid system. J Pain Palliat Care Pharmacother 2006; 20(1): 5-13.
5. Caudill-Slosberg MA, Schwartz LM, Woloshin S. Office visits and analgesic prescriptions for musculoskeletal pain in US: 1980 vs.2000. Pain 2004; 109(3): 514-519.
6. Trescot AM, Helm S, Hansen H, et al. Opioids in the management of chronic non-cancer pain: an update of American Society of the Interventional Pain Physicians' (ASIPP) Guidelines. Pain Physician 2008; 11(2 Suppl): S5-S62. (Pubitemid 351682078)
7. Sullivan MD, Edlund MJ, Fan MY, Devries A, Brennan Braden J, Martin BC. Trends in use of opioids for non-cancer pain conditions 2000-2005 in commercial and Medicaid insurance plans: the TROUP study. Pain 2008; 138(2): 440-449.
8. Parsells Kelly J, Cook SF, Kaufman DW, Anderson T, Rosenberg L, Mitchell AA. Prevalence and characteristics of opioid use in the US adult population. Pain 2008; 138(3): 507-513.
9. Hudson TJ, Edlund MJ, Steffick DE, Tripathi SP, Sullivan MD. Epidemiology of regular prescribed opioid use: results from a national, population-based survey. J Pain Symptom Manage 2008; 36(3): 280-288.
10. Chou R, Clark E, Helfand M. Comparative efficacy and safety of longacting oral opioids for chronic non-cancer pain: a systematic review. J Pain Symptom Manage 2003; 26(5): 1026-1048. (Pubitemid 37324684)
11. Ballantyne JC, Mao J. Opioid therapy for chronic pain. N Engl J Med 2003; 349(20): 1943-1953.
12. Martell BA, O'Connor PG, Kerns RD, et al. Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction. Ann Intern Med 2007; 146(2): 116-127. (Pubitemid 351640015)
13. Furlan AD, Sandoval JA, Mailis-Gagnon A, Tunks E. Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects. CMAJ 2006; 174(11): 1589-1594. (Pubitemid 43829515)
14. Ballantyne JC, LaForge KS. Opioid dependence and addiction during opioid treatment of chronic pain. Pain 2007; 129(3): 235-255. (Pubitemid 46754581)
15. Noble M, Tregear SJ, Treadwell JR, Schoelles K. Long-term opioid therapy for chronic noncancer pain: a systematic review and metaanalysis of efficacy and safety. J Pain Symptom Manage 2008; 35(2): 214-228.
16. Gilson AM, Maurer MA, Joranson DE. State medical board members' beliefs about pain, addiction, and diversion and abuse: a changing regulatory environment. J Pain 2007; 8(9): 682-691.
17. Ballantyne JC. Opioid analgesia: perspectives on right use and utility. Pain Physician 2007; 10(3): 479-491.
18. Substance Abuse and Mental Health Services Administration. Results from the 2005 National Survey on Drug Use and Health, national findings. Rockville, MD: Office of Applied Statistics; 2006.
19. A consensus statement from the American Academy of Pain Medicine and the American Pain Society. The use of opioids for the treatment of Chronic Pain. Clin J Pain 1997; 13(1): 6-8.
20. Katz N. Opioids: after thousands of years, still getting to knowyou. Clin J Pain 2007; 23(4): 303-306. (Pubitemid 46650022)
21. Wasan AD, Correll DJ, Kissin I, O'Shea S, Jamison RN. Iatrogenic addiction in patients treated for acute or subacute pain: a systematic review. J Opioid Manag 2006; 2(1): 16-22.
22. Zacny J, Bigelow G, Compton P, Foley K, Iguchi M, Sannerud C. College on problems of drug dependence taskforce on prescription opioid non-medical use and abuse: position statement. Drug Alcohol Depend 2003; 69(3): 215-232. (Pubitemid 36293934)
23. Moore TJ, Cohen MR, Furberg CD. Serious adverse drug events reported to the Food and Drug Administration, 1998-2005. Arch Intern Med 2007; 167(16): 1752-1759.
24. Hojsted J, Sjogren P. An update on the role of opioids in the management of chronic pain of nonmalignant origin. Curr Opin Anaesthesiol 2007; 20(5): 451-455. (Pubitemid 47430573)
25. Paulozzi LJ, Budnitz DS, Xi Y. Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiol Drug Saf 2006; 15(9): 618-627. (Pubitemid 44404658)
26. Paulozzi LJ, Ryan GW. Opioid analgesics and rates of fatal drug poisoning in the United States. Am J Prev Med 2006; 31(6): 506-511. (Pubitemid 44880582)
27. Savage SR. Long-term opioid therapy: assessment of consequences and risks. J Pain Symptom Manage 1996; 11(5): 274-286. (Pubitemid 26129963)
28. Von Korff M, Saunders K, Thomas Ray G, et al. De facto long-term opioid therapy for noncancer pain. Clin J Pain 2008; 24(6): 521-527.
29. Saunders KW, Davis RL, Stergachis A. Group health cooperative. In Pharmacoepidemiology (4th edn), Strom BL (ed.). John Wiley and Sons: West Sussez, England, 2005; 223-239.
30. Selby JV, Smith DH, Johnson ES, Raebel MA. Kaiser permanente medical care program. In Pharmacoepidemiology, Strom BL (ed.). John Wiley and Sons: West Sussex, England, 2005; 241-259.
31. Boudreau DM, Doescher MP, Jackson JE, Fishman PA, Saver BG. Impact of healthcare delivery system on where HMO-enrolled seniors purchase medications. Ann Pharmacother 2004; 38(7-8): 1317-1318.
32. Ries LA, Eisener MP, Kosary CL, et al., SEER cancer statistics review, 1975-2001. 2004; http://seer.cancer.gov/csr/1975-2001/. Accessed [1 October 2008].
33. Fay MP, Tiwari RC, Feuer EJ, Zou Z. Estimating average annual percent change for disease rates without assuming constant change. Biometrics 2006; 62(3): 847-854. (Pubitemid 44410643)
34. U.S. Census Bureau. Fact Finder. http://www.factfinder.census.gov/ home/saff/main.html?-lang=en. Accessed [13 April 2009].
35. Curtis LH, Stoddard J, Radeva JI, et al. Geographic variation in the prescription of schedule II opioid analgesics among outpatients in the United States. Health Serv Res 2006; 41(3 Pt 1): 837-855. (Pubitemid 43725352)
36. Kalso E, Allan L, Dellemijn PL, et al. Recommendations for using opioids in chronic non-cancer pain. Eur J Pain 2003; 7(5): 381-386. (Pubitemid 37101777)
37. Veterans Health Administration Department of Defense. VA/DoD clinical practice guideline for the management of opioid therapy for chronic pain (version 1.0)Washington, D.C.: Veterans Health Administration Department of Defense; 2003.
38. American Pain Society. Principles of analgesic use in the treatment of acute pain and cancer painGlenview: American Pain Society; 2003.
39. National Pharmaceutical Council I. Pain: current understanding of assessment, management and treatmentsReston, VA: National Pharmaceutical Council, Inc; 2001.
40. Marks RM, Sachar EJ. Undertreatment of medical inpatients with narcotic analgesics. Ann Intern Med 1973; 78(2): 173-181.
41. Wall PD. The prevention of postoperative pain. Pain 1988; 33(3): 289-290.
42. Portenoy RK, Lesage P. Management of cancer pain. Lancet 1999; 353(9165): 1695-1700.
43. Agency for Health Care Policy and Research. Management of Cancer Pain: Guideline Overview. J Natl Med Assoc 1994; 86(8): 571-573 634.
44. Sayers M, Marando R, Fisher S, Aquila A, Morrison B, Dailey T. No need for pain. J Healthc Qual 2000; 22(3): 10-15.
45. Eriksen J, Sjogren P, Bruera E, Ekholm O, Rasmussen NK. Critical issues on opioids in chronic non-cancer pain: an epidemiological study. Pain 2006; 125(1-2): 172-179. (Pubitemid 44498976)
46. Portenoy RK, Farrar JT, Backonja MM, et al. Long-term use of controlled-release oxycodone for noncancer pain: results of a 3-year registry study. Clin J Pain. 2007; 23 4 287-299.
47. Chou R, Ballantyne JC, Fanciullo GJ, Fine PG, Miaskowski C. Research gaps on use of opioids for chronic noncancer pain: findings from a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. J Pain 2009; 10(2): 147-159.
48. Brennan F, Carr DB, Cousins M. Pain management: a fundamental human right. Anesth Analg 2007; 105(1): 205-221. (Pubitemid 46975867)
49. Ballantyne JC. Opioid misuse in oncology pain patients. Curr Pain Headache Rep 2007; 11(4): 276-282.
50. Substance Abuse and Mental Health Services Administration. Mortality data from the Drug Abuse Awareness Network, 2002Rockville, MD: Office of Applied Statistics; 2004.
51. Inciardi JA, Surratt HL, Kurtz SP, Cicero TJ. Mechanisms of prescription drug diversion among drug-involved club- and street-based populations. Pain Med 2007; 8(2): 171-183.
52. United States General Accounting Office. Prescription drugs: oxycontin abuse and diversion and efforts to address the problemWashington, D.C.: United States General Accounting Office; 2003.
53. Sewester CS, Dombeck C, Olin BR, Kastrup EK, Hebel SK. Drugs facts and comparisons. Lippincott Co: St. Louis, MO, 2004.
54. Sullivan MD, Edlund MJ, Zhang L, Unutzer J, Wells KB. Association between mental health disorders, problem drug use, and regular prescription opioid use. Arch Intern Med 2006; 166(19): 2087-2093. (Pubitemid 44631396)